
1. protein cell. 2017 apr;8(4):284-295. doi: 10.1007/s13238-016-0350-x. epub 2016
dec 19.

functional characterization human equilibrative nucleoside transporter 1.

huang w(1), zeng x(1), shi y(1), liu m(2).

author information: 
(1)beijing advanced innovation center structural biology, tsinghua-peking
joint center life sciences, school life sciences, tsinghua university,
beijing, 100084, china.
(2)beijing advanced innovation center structural biology, tsinghua-peking
joint center life sciences, school life sciences, tsinghua university,
beijing, 100084, china. liuminhao@biomed.tsinghua.edu.cn.

equilibrative nucleoside transporters (ents), facilitate cross-membrane
transport nucleosides nucleoside-derived drugs, play important role 
the salvage pathways nucleotide synthesis, cancer chemotherapy, treatment 
for virus infections. functional characterization ents molecular level 
remains technically challenging hence scant. study, report
successful purification biochemical characterization human equilibrative
nucleoside transporter 1 (hent1) vitro. hek293f-derived, recombinant hent1
is homogenous functionally active proteoliposome-based counter flow
assays. hent1 transports substrate adenosine km 215 ± 34 µmol/l and
a vmax 578 ± 23.4 nmol mg-1 min-1. adenosine uptake hent1 competitively 
inhibited nitrobenzylmercaptopurine ribonucleoside (nbmpr), nucleosides,
deoxynucleosides, nucleoside-derived anti-cancer anti-viral drugs.
binding hent1 adenosine, deoxyadenosine, adenine isothermal
titration calorimetry general agreement results competitive
inhibition assays. results validate hent1 bona fide target for
potential drug target serve useful basis future biophysical and
structural studies.

doi: 10.1007/s13238-016-0350-x 
pmcid: pmc5359181
pmid: 27995448  [indexed medline]

